Company / Depreciation & Amortization
Minerva Neurosciences, Inc. Depreciation & Amortization History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$5.4K
FY2024
5-year range
$5.4K / $17.5K
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $16,011 to $5,442 over the past 3 years.
Based on SEC 10-K filings.
$5,442 in FY2024 with a 5-year CAGR of -20.8%.
Improved from $16,011 to $5,442 over the past 3 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -30.2%
- 5-Year CAGR
- -20.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.8%, indicating a declining trend.
- In FY2024, depreciation & amortization increased 0.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.4K | +0.0% |
| FY2023 | $5.4K | - |
| FY2022 | - | - |
| FY2021 | $16.0K | -8.3% |
| FY2020 | $17.5K | +0.0% |
| FY2019 | $17.5K | +57.4% |
| FY2018 | $11.1K | -35.8% |
| FY2017 | $17.3K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026